Terms: = Skin cancer AND AXIN2, AXIL, 8313, ENSG00000168646, MGC126582, DKFZp781B0869 AND Treatment
7 results:
1. Novel GSK-3 kinase inhibitor Pym-5 induces GSK-3β rather than GSK-3α-dependent melanogenesis in murine melanoma cells.
Jia Q; Tao L; Zhou Y; Song L; Wei Z; Lu T; Woodgett JR; Lu Y
J Dermatol Sci; 2022 Jun; 106(3):170-180. PubMed ID: 35641396
[TBL] [Abstract] [Full Text] [Related]
2. Phase 1 study of single-agent WNT974, a first-in-class Porcupine inhibitor, in patients with advanced solid tumours.
Rodon J; Argilés G; Connolly RM; Vaishampayan U; de Jonge M; Garralda E; Giannakis M; Smith DC; Dobson JR; McLaughlin ME; Seroutou A; Ji Y; Morawiak J; Moody SE; Janku F
Br J Cancer; 2021 Jul; 125(1):28-37. PubMed ID: 33941878
[TBL] [Abstract] [Full Text] [Related]
3. The Effect of Phototherapy on cancer Predisposition Genes of Diabetic and Normal Human skin Fibroblasts.
Chotikasemsri P; Tangtrakulwanich B; Sangkhathat S
Biomed Res Int; 2017; 2017():7604861. PubMed ID: 28386563
[TBL] [Abstract] [Full Text] [Related]
4. Characteristics of cultured desmoid cells with different CTNNB1 mutation status.
Hamada S; Urakawa H; Kozawa E; Arai E; Ikuta K; Sakai T; Ishiguro N; Nishida Y
Cancer Med; 2016 Feb; 5(2):352-60. PubMed ID: 26686699
[TBL] [Abstract] [Full Text] [Related]
5. Activating the Wnt/β-Catenin Pathway for the treatment of Melanoma--Application of LY2090314, a Novel Selective Inhibitor of Glycogen Synthase Kinase-3.
Atkinson JM; Rank KB; Zeng Y; Capen A; Yadav V; Manro JR; Engler TA; Chedid M
PLoS One; 2015; 10(4):e0125028. PubMed ID: 25915038
[TBL] [Abstract] [Full Text] [Related]
6. Tissue inhibitor of metalloproteinase 2 inhibits activation of the β-catenin signaling in melanoma cells.
Xia Y; Wu S
Cell Cycle; 2015; 14(11):1666-74. PubMed ID: 25839957
[TBL] [Abstract] [Full Text] [Related]
7. Predictors of clinical effectiveness of Hymenoptera venom immunotherapy.
Ruëff F; Vos B; Oude Elberink J; Bender A; Chatelain R; Dugas-Breit S; Horny HP; Küchenhoff H; Linhardt A; Mastnik S; Sotlar K; Stretz E; Vollrath R; Przybilla B; Flaig M
Clin Exp Allergy; 2014; 44(5):736-46. PubMed ID: 24447114
[TBL] [Abstract] [Full Text] [Related]
